CAREDX, INC. CDNA Cash Flow

Caredx, inc. (CDNA)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12
Operating activities:
Net loss
-21,968	-46,781	-55,560	-39,756	-13,707	781	-3,542	-5,059
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
22,417	7,138	1,744	1,998	1,341	535	72	69
Noncash Lease Expense
1,621	0	0	-	-	-	-	-
Amortization of deferred revenue
-	-	-	45	130	727	193	187
Revaluation of common stock warrant liability to estimated fair value
319	-22,978	-29,622	-250	0	-	525	-2
Amortization of inventory fair market value adjustment
0	234	418	4,175	0	0	-	-
Loss on disposal of property and equipment
-160	0	-10	0	2	0	0	-
Depreciation and amortization
5,523	4,215	3,727	2,920	796	512	663	1,072
Revaluation of contingent consideration to estimated fair value
210	1,017	1,180	-456	-126	-1,239	0	-
Amortization of debt discount and noncash interest expense
0	2,232	3,452	-101	247	799	553	634
Revaluation of warrants and derivative liabilities to estimated fair value
-	-	-	-	-	225	-	-
Non-cash goodwill impairment
0	0	1,958	13,021	0	0	-	-
Debt extinguishment expenses
0	5,831	274	0	0	-	-	-
Non-cash income tax benefit in connection with business acquisition
-	-	-	-	-	1,500	0	0
Changes in operating assets and liabilities:
Accounts receivable
12,675	3,967	109	-1,047	-320	417	1,318	150
Inventory
1,270	-363	-1,025	-492	80	168	-58	152
Prepaid and other assets
829	502	84	-999	823	310	4	-146
Operating leases liabilities, net
-1,854	-	-	-	-	-	-	-
Accounts payable
1,351	-168	292	-620	489	510	-19	-113
Accrued compensation
3,115	4,291	1,065	977	682	298	408	-76
Accrued royalties
-	-	-	21	1	-2,563	1,259	843
Accrued and other liabilities
3,029	719	-1,233	-105	1,240	364	-91	199
Change in deferred revenue
-	-	-	0	-	-	1,083	1,000
Change in deferred taxes
1,280	1,607	2,088	1,340	0	0	-	-
Net cash used in operating activities
-2,769	-4,007	-14,307	-16,523	-9,752	-3,350	-546	-1,776
Investing activities:
Additions of capital expenditures, net
2,201	2,035	186	-	-	-	-	-
Acquisition of intangible assets
1,148	5,202	0	0	-	-	-	-
Acquisition of business
18,230	692	5,919	-	-	-	-	-
Investment in equity securities
1,000	0	0	-	-	-	-	-
Purchase of investments
-	-	-	-	-	-	-	1,623
Sales of investments
-	-	-	-	-	-	-	-383
Maturities of investments
-	-	-	-	-	-	-	2,023
Purchase of property and equipment, net
-	-	-	549	1,199	733	98	141
Net cash used in investing activities
-22,579	-7,929	-6,105	-21,121	-1,199	-1,333	-98	642
Financing activities:
Proceeds from issuance of common stock under employee stock purchase plan
760	287	94	304	-	-	0	-
Taxes paid related to net share settlement of restricted stock units
4,153	698	0	0	-	-	-	-
Change in short-term credit facility
0	-677	0	0	-	-	-	-
Restricted cash collateral for debt
-	-	-	-	0	-	-	-
Proceeds from private placement and subsequent financing, net of issuance costs
-	-	-	20,622	0	0	-	-
Proceeds from exercise of warrants
100	11,000	989	0	0	-	-	-
Proceeds from exercise of stock options
3,553	1,480	262	19	46	19	0	10
Restricted cash on operating leases
-	-	-	-	0	-	-	-
Proceeds from initial public offering, net of underwriters discount
-	-	-	-	-	39,246	0	0
Payments of initial public offering costs
-	-	-	-	-	3,733	0	0
Proceeds from subordinated convertible debt, net of issuance costs
-	-	-	-	-	4,982	0	-
Proceeds from issuance of common stock, net of issuance costs
0	52,910	18,328	7,926	0	0	-	-
Proceeds from issuance of convertible preferred stock, net of issuance costs
-	-	-	-	-	-	-	2,941
Proceeds from debt, net of issuance costs
0	14,282	24,002	0	15,625	0	0	14,650
Principal payments on debt and finance lease obligations
172	28,089	14,359	3,944	11,466	4,528	58	-
Proceeds from issuances of common stock under equity incentive plans
-	-	-	-	203	0	-	-
Change in bank overdraft obligation
0	0	63	0	0	-	-	-
Net cash used in financing activities
-132	50,268	29,379	24,927	4,408	35,986	-58	4,607
Effect of exchange rate changes on cash and cash equivalents
-849	2	106	83	0	0	-	-
Principal payments on debt
-	-	-	-	-	-	-	12,994
Net decrease in cash, cash equivalents and restricted cash
-26,329	38,334	9,073	-12,634	-6,543	31,303	-702	3,473
Supplemental disclosures of cash information
Cash paid for interest
22	1,774	3,270	867	1,364	1,207	1,506	1,966
Shares issued in lieu of payment
209	0	1,145	0	0	-	-	-
Deferred purchase consideration
0	0	0	5,700	0	-	-	-
Accrued interest capitalized to debt principal
0	0	984	0	0	-	-	-
Property and equipment purchased under capital leases
-	-	-	-	25	193	0	43
Deferred payments for intangible assets
7,207	0	0	7,205	0	14,242	0	0
Operating lease right of use assets
6,138	-	-	-	-	-	-	-
Debt assumed as part of acquisition
-	-	-	13,421	0	0	-	-
Purchased of capital expenditures in accounts payable and accrued liabilities
576	0	0	13,064	0	0	-	-
Issuance of common stock upon conversion of convertible debt
0	38,852	0	0	-	-	-	-
Offering costs included in accounts payable
0	361	0	0	-	-	-	-
ESPP shares included in accrued compensation
703	341	0	0	-	-	-	-
Conversion of convertible preferred stock to common stock upon initial public offering
-	-	-	-	-	149,444	0	0
Conversion of convertible preferred stock warrants to common stock warrants upon initial public offering
-	-	-	-	-	539	0	0
Conversion of convertible preferred stock to common stock upon initial public offering
-	-	-	-	-	5,108	0	0
Issuance of common stock for Board of Director services
-	-	-	-	-	34	0	0
Common stock warrants issued upon debt financing
0	784	0	0	90	0	0	-
Contingent consideration
1,442	2,689	0	0	-	-	-	-
Allenex AB [Member]
Acquisition of business and noncontrolling interests, net of cash acquired
-	-	-	20,572	-	-	-	-
Conexio [Member]
Acquisition of business, net of cash acquired
-	-	-	0	-	600	0	0
Conexio
Contingent payments related to acquisition
225	225	0	0	-	-	-	-